Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,044) with videos related to
Page
of 105
Sort By:
Journal of Medicinal Chemistry
|
August 18, 2016
Small Molecule Reversible Inhibitors of Bruton's Tyrosine Kinase (BTK): Structure-Activity Relationships Leading to the Identification of 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]-9H-carbazole-1-carboxamide (BMS-935177)
George V De Lucca, Qing Shi, Qingjie Liu, et al.
The Journal of Clinical Investigation
|
February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Na Zhao, Jin Cao, Longyong Xu, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2020
Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist
Robert J Cherney, Lyndon A M Cornelius, Anurag Srivastava, et al.
Women & Health
|
May 18, 2026
Menopause in Brazil: lived experiences, inequities, and opportunities for inclusive care (MARIE-Brazil WP2a)
Cristina Benetti-Pinto, Gabriela Pravatta Rezende, Renan Massao Nakamura, et al.
Nature Methods
|
July 10, 2023
A positively tuned voltage indicator for extended electrical recordings in the brain
S Wenceslao Evans, Dong-Qing Shi, Mariya Chavarha, et al.
Scientific Reports
|
April 26, 2026
A perspective on economic barriers and disparities in access to hormone replacement therapy in LMICs (MARIE-WP2b)
Gayathri Delanerolle, Snehal Ghosh, Paula Briggs, et al.
Journal of Medicinal Chemistry
|
September 2, 2016
Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers
Scott H Watterson, George V De Lucca, Qing Shi, et al.
Stroke
|
August 25, 2025
Endovascular Therapy Versus Medical Management for Large Ischemic Infarct: 1-Year Outcomes of the ANGEL-ASPECT Trial
Xiaochuan Huo, Dapeng Sun, Thanh N Nguyen, et al.
Journal of Medicinal Chemistry
|
October 23, 2019
Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy
David Marcoux, James J-W Duan, Qing Shi, et al.
Acta Neuropathologica
|
May 21, 2014
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
Tara Spence, Patrick Sin-Chan, Daniel Picard, et al.
Page
of 105
Search research articles
Search
Showing results (1031-1040 of 1,044) with videos related to
Sort By:
Page
of 105
Journal of Medicinal Chemistry
|
August 18, 2016
Small Molecule Reversible Inhibitors of Bruton's Tyrosine Kinase (BTK): Structure-Activity Relationships Leading to the Identification of 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]-9H-carbazole-1-carboxamide (BMS-935177)
George V De Lucca, Qing Shi, Qingjie Liu, et al.
The Journal of Clinical Investigation
|
February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Na Zhao, Jin Cao, Longyong Xu, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2020
Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist
Robert J Cherney, Lyndon A M Cornelius, Anurag Srivastava, et al.
Women & Health
|
May 18, 2026
Menopause in Brazil: lived experiences, inequities, and opportunities for inclusive care (MARIE-Brazil WP2a)
Cristina Benetti-Pinto, Gabriela Pravatta Rezende, Renan Massao Nakamura, et al.
Nature Methods
|
July 10, 2023
A positively tuned voltage indicator for extended electrical recordings in the brain
S Wenceslao Evans, Dong-Qing Shi, Mariya Chavarha, et al.
Scientific Reports
|
April 26, 2026
A perspective on economic barriers and disparities in access to hormone replacement therapy in LMICs (MARIE-WP2b)
Gayathri Delanerolle, Snehal Ghosh, Paula Briggs, et al.
Journal of Medicinal Chemistry
|
September 2, 2016
Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers
Scott H Watterson, George V De Lucca, Qing Shi, et al.
Stroke
|
August 25, 2025
Endovascular Therapy Versus Medical Management for Large Ischemic Infarct: 1-Year Outcomes of the ANGEL-ASPECT Trial
Xiaochuan Huo, Dapeng Sun, Thanh N Nguyen, et al.
Journal of Medicinal Chemistry
|
October 23, 2019
Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy
David Marcoux, James J-W Duan, Qing Shi, et al.
Acta Neuropathologica
|
May 21, 2014
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
Tara Spence, Patrick Sin-Chan, Daniel Picard, et al.
Page
of 105